Currently, there are limited supplies of the reagents used for HIV-1 Western Blot and HIV-2 EIA testing. In order to conserve the remaining reagent, a controlled process of batch testing was implemented. Therefore, you will likely see additional delays in receiving these supplemental test results.
Read about our plan to mitigate this on the Communications page by clicking this link: Communications
We sincerely hope to see you at this year’s AABB Annual Meeting in San Antonio, TX on October ...
On June 13, 2019, CTS provided information regarding the manufacturer’s discontinuation of HIV...
Honor Your StaffCelebrate Lab Week, and honor yourself and your colleagues as a vital part of the la...
As a friendly reminder, airlines often change their routine flights and cargo hours for holidays. We...
In July, all 5 CTS laboratories will convert from the current Grifols Ultrio Plus NAT triplex assay ...
We received an updated WNV package insert; please note the manufacturer and license number has been ...